Instylla Advances Approval Process for Innovative Embrace Hydrogel Embolic System Instylla has submitted the final module for FDA approval of its Embrace Hydrogel Embolic System, marking a milestone in cancer treatment.

Instylla Advances Approval Process for Innovative Embrace Hydrogel Embolic System #USA #FDA_Approval #Bedford #Instylla #Embrace_HES